| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/16/2009 | US20090098562 Methods for identifying stem cells based on nuclear morphotypes |
| 04/16/2009 | US20090098561 Higher-order cellular information processing devices |
| 04/16/2009 | US20090098560 Purification method and kits |
| 04/16/2009 | US20090098559 Forensic swab and kit |
| 04/16/2009 | US20090098558 Detection, identification and differentiation of proteus species using the spacer region |
| 04/16/2009 | US20090098557 Identification of genetic markers associated with parkinson disease |
| 04/16/2009 | US20090098556 Genetic Test For PSE-Susceptible Turkeys |
| 04/16/2009 | US20090098555 Methods and applications for stitched dna barcodes |
| 04/16/2009 | US20090098554 Method and composition for cancer diagnosis and treatment |
| 04/16/2009 | US20090098553 Urine gene expression ratios for detection of cancer |
| 04/16/2009 | US20090098552 Methods and compositions for analyzing ahasl genes |
| 04/16/2009 | US20090098551 Methods and products related to genotyping and dna analysis |
| 04/16/2009 | US20090098550 Mri contrast agents and high-throughput screening by mri |
| 04/16/2009 | US20090098549 Selex and photoselex |
| 04/16/2009 | US20090098548 Modulators of enzymatic nucleic acid elements mobilization |
| 04/16/2009 | US20090098547 Methods for Identifying DNA Copy Number Changes Using Hidden Markov Model Based Estimations |
| 04/16/2009 | US20090098546 Methods of Screening for LTRPC7 Modulators |
| 04/16/2009 | US20090098545 In vitro assay for identification of allergenic proteins |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098543 Gene methylation in lung cancer diagnosis |
| 04/16/2009 | US20090098542 Gene Methylation in Colon Cancer Diagnosis |
| 04/16/2009 | US20090098541 Devices and processes for analysing individual cells |
| 04/16/2009 | US20090098540 Recirculating microfluidic device and methods of use |
| 04/16/2009 | US20090098539 Methods and Kits for Detecting an Enzyme Capable of Modifying a Nucleic Acid |
| 04/16/2009 | US20090098538 Prognostic and diagnostic method for disease therapy |
| 04/16/2009 | US20090098537 Biomarker for Sensitivity to mTOR Inhibitor Therapy in Kidney Cancer |
| 04/16/2009 | US20090098536 Method for subgroup analysis in subjects having or being suspected of having inflammatory disease, use of anti-p38MAPK antibodies, kits and their use |
| 04/16/2009 | US20090098535 Upregulation of rack-1 in melanoma and its use as a marker |
| 04/16/2009 | US20090098534 Full Karyotype Single Cell Chromosome Analysis |
| 04/16/2009 | US20090098533 Methods and kits for investigating cancer |
| 04/16/2009 | US20090098532 Probes and Methods for Hepatitis C Virus Typing Using Single Probe Analysis |
| 04/16/2009 | US20090098531 Detecting hepatitis b virus |
| 04/16/2009 | US20090098530 Cell Line For Producing Coronaviruses |
| 04/16/2009 | US20090098529 Methods for attenuating virus strains for diagnostic and therapeutic uses |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098527 Biological organism identification product and methods |
| 04/16/2009 | US20090098301 Solid support having electrostatic layer and use thereof |
| 04/16/2009 | US20090098163 Mutant F. turlarensis strain and uses thereof |
| 04/16/2009 | US20090098161 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098160 sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding; CD55 and CD59 removal prevents the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098157 Helicobacter Pylori Vaccination |
| 04/16/2009 | US20090098152 Vaccines Containing Canine Parvovirus Genetic Variants |
| 04/16/2009 | US20090098146 Methods to diagnose a required regulation of trophoblast invasion |
| 04/16/2009 | US20090098141 IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same |
| 04/16/2009 | US20090098135 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 04/16/2009 | US20090098132 Composition and method for treating lupus nephritis |
| 04/16/2009 | US20090098131 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098128 NPC1L1 orthologues |
| 04/16/2009 | US20090098126 Method and kit for the detection of adenoviruses |
| 04/16/2009 | US20090098123 Hcv coreceptor and methods of use thereof |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098115 Cell lines and animal models of HER2 expressing tumors |
| 04/16/2009 | US20090098107 Method of Detecting Relative Risk for the Onset of Atopic Dermatitis by Gene Single Nucleotide Polymorphism Analysis |
| 04/16/2009 | US20090098104 Method for Diagnosing Cardiovascular Diseases |
| 04/16/2009 | US20090098100 Hormonally up-regulated, neu-tumor-associated kinase |
| 04/16/2009 | US20090098083 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 04/16/2009 | US20090098056 Alpk1 gene variants in diagnosis risk of gout |
| 04/16/2009 | US20090098055 Methods and Compositions for Diagnosing Disease |
| 04/16/2009 | US20090098053 La1 - the genome of a lactobacillus strain |
| 04/16/2009 | US20090098023 Device for removing filter from fluid transfer tube |
| 04/16/2009 | US20090095642 Transition metal complexes with pyridyl-imidazole ligands |
| 04/16/2009 | US20090095628 Cleavable surfactants |
| 04/16/2009 | US20090095624 Electroactive complex, electroactive probe and preparation method |
| 04/16/2009 | US20090095419 Device for removing filter from fluid transfer tube |
| 04/16/2009 | US20090095091 Method and Apparatus for Stripping a Contact-Limiting Element from a Pipette Probe |
| 04/16/2009 | DE19934510B4 Verfahren zum Nachweis von Mikroorganismen A method for detection of microorganisms |
| 04/16/2009 | DE19520398B4 Magnetisches Pigment Magnetic pigment |
| 04/16/2009 | DE102008049290A1 Zielmolekül-Evaluierungs-Verfahren und Vorrichtung Target molecule evaluation method and apparatus |
| 04/16/2009 | DE102005047301B4 Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen A method for detecting the Virenabreicherung for the validation of filters and filtration processes |
| 04/16/2009 | CA2702584A1 Methods, compositions and kits for the improved detection of small rna molecules |
| 04/16/2009 | CA2702330A1 Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy |
| 04/16/2009 | CA2702276A1 Microfluidic platforms for multi-target detection |
| 04/16/2009 | CA2702241A1 Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas |
| 04/16/2009 | CA2702217A1 Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 04/16/2009 | CA2702212A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | CA2702175A1 Differentiation between brca1-associated and sporadic tumours |
| 04/16/2009 | CA2702172A1 Method and kit for quantitatively determining small, dense ldl cholesterol |
| 04/16/2009 | CA2702169A1 Sequence variants for inferring human pigmentation patterns |
| 04/16/2009 | CA2702121A1 Measurement of arylesterase enzymatic activity and assessment of genetic polymorphisms located in the pon1 gene as a diagnostic tool in autism-spectrum disorders |
| 04/16/2009 | CA2702058A1 Engineered dendritic cells and uses for the treatment of cancer |
| 04/16/2009 | CA2702007A1 Systems and methods for measuring translation activity in viable cells |
| 04/16/2009 | CA2701923A1 Assembly of large nucleic acids |
| 04/16/2009 | CA2701362A1 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 04/16/2009 | CA2699978A1 Mediator-stabilized reagent compositions for use in biosensor electrodes |
| 04/16/2009 | CA2640985A1 Reagents and methods for detecting neisseria gonorrhoeae |
| 04/15/2009 | EP2048506A1 Postprandial hyperglycemia marker, method for determination thereof, and use thereof |
| 04/15/2009 | EP2048499A1 Method and apparatus for correcting ambient temperature effect in biosensor |
| 04/15/2009 | EP2048249A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 04/15/2009 | EP2048248A1 Method of amplifying a target nucleic acid by rolling circle amplification |
| 04/15/2009 | EP2048247A1 Method for production of pcr amplification product and use thereof |
| 04/15/2009 | EP2048246A1 Method for obtaining oligonucleotide |
| 04/15/2009 | EP2048245A1 A totally-enclosed device for quick detection of target nucleic acid amplification product |
| 04/15/2009 | EP2048244A1 PTPL1 as a biomarker of survival in breast cancer |
| 04/15/2009 | EP2048243A1 Use of clec1B for the determination of cardiovascular and thrombotic risk |
| 04/15/2009 | EP2048242A1 Microarray for expression analysis of cellular glycosylation |
| 04/15/2009 | EP2048241A1 Molecular markers for cancer prognosis |
| 04/15/2009 | EP2048235A2 Synthetic Mammalian Alpha-N-Acetylglucosaminidase and Genetic Sequences Encoding Same |
| 04/15/2009 | EP2048228A2 Human liver progenitors |
| 04/15/2009 | EP2048223A1 Cell chip |